España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Elicio Therapeutics
ELTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$8.54
0.44
5.43%
At close: -
$8.96
0.42
4.92%
After Hours: 6:54 PM EDT
Get Report
Comment
Elicio Therapeutics (ELTX) Forecast
News
Earnings
Elicio Therapeutics (ELTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Elicio Therapeutics (NASDAQ:ELTX) Stock
Elicio Therapeutics Stock (NASDAQ: ELTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 30, 2025
Elicio Therapeutics shares are trading lower ...
Benzinga Newsdesk
Elicio Therapeutics Enters Definitive Securit...
Benzinga Newsdesk
Thursday, January 23, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, January 22, 2025
Elicio Therapeutics Gets FDA Support to Advan...
Benzinga Newsdesk
Tuesday, January 21, 2025
Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, January 17, 2025
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, December 12, 2024
Elicio Therapeutics Highlights Results for EL...
Benzinga Newsdesk
Wednesday, November 13, 2024
Elicio Therapeutics Q3 2024 GAAP EPS $(1.39) ...
Benzinga Newsdesk
Elicio Therapeutics Files For Offering Of Up ...
Benzinga Newsdesk
Thursday, November 07, 2024
Elicio Therapeutics Shares ELI-002 Phase 1 Da...
Benzinga Newsdesk
Thursday, October 31, 2024
Jones Trading Initiates Coverage On Elicio Th...
Benzinga Newsdesk
Tuesday, October 01, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Friday, September 13, 2024
Elicio Therapeutics Announces 3 Upcoming Pres...
Benzinga Newsdesk
Friday, August 23, 2024
HC Wainwright & Co. Reiterates Buy on Elicio ...
Benzinga Newsdesk
Tuesday, August 13, 2024
Elicio Therapeutics Q2 EPS $(0.64) Beats $(0....
Benzinga Newsdesk
Friday, June 28, 2024
Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday?
Vandana Singh
Elicio Therapeutics Prices $11.5M Underwritte...
Benzinga Newsdesk
Elicio Therapeutics shares are trading lower ...
Benzinga Newsdesk
Thursday, June 27, 2024
Elicio Therapeutics Announces Proposed Public...
Benzinga Newsdesk
Elicio Therapeutics shares are trading lower ...
Benzinga Newsdesk
Elicio Therapeutics Announces Prelim. Disease...
Benzinga Newsdesk
Thursday, June 06, 2024
HC Wainwright & Co. Reiterates Buy on Elicio ...
Benzinga Newsdesk
Friday, May 24, 2024
Elicio Therapeutics On May 23 Announced Prel...
Benzinga Newsdesk
Wednesday, May 22, 2024
HC Wainwright & Co. Reiterates Buy on Elicio ...
Benzinga Newsdesk
Thursday, May 16, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, May 15, 2024
Elicio Therapeutics Q1 2024 Adj EPS $(1.15) M...
Benzinga Newsdesk
Wednesday, May 01, 2024
HC Wainwright & Co. Maintains Buy on Elicio T...
Benzinga Newsdesk
Thursday, April 25, 2024
Elicio Therapeutics To Present New Preliminar...
Benzinga Newsdesk
Friday, April 05, 2024
Elicio Therapeutics To Present Updated Clinic...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Monday, April 01, 2024
Oppenheimer Reiterates Perform on Elicio Ther...
Benzinga Newsdesk
Tuesday, March 19, 2024
Benzinga's 2024 Virtual Healthcare Summit: What's Next In Health?
Abbey Higginbotham
Monday, March 18, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Elicio Therapeutics shares are trading higher...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Elicio Therapeutics Announces $6.0M Private P...
Benzinga Newsdesk
Thursday, February 08, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, February 07, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Monday, February 05, 2024
Elicio Therapeutics Announces Publication Of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy
Jeremy Golden
-
Sponsored
Thursday, February 01, 2024
Elicio Therapeutics Dosed First Patient In Ph...
Benzinga Newsdesk
Wednesday, January 31, 2024
First Patient Dosed In Phase 2 Study Of Elicio Therapeutics' ELI-002 7P
Jeremy Golden
-
Sponsored
Monday, January 29, 2024
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutics' AMPLIFY-201 Phase 1 Solid Tumor Study Of ELI-002
Jeremy Golden
-
Sponsored
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Thursday, January 25, 2024
Elicio Therapeutics shares are trading higher...
Benzinga Newsdesk
Elicio Therapeutics Publishes Preclinical Dat...
Benzinga Newsdesk
Wednesday, January 24, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Monday, January 22, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Friday, January 19, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, January 17, 2024
Elicio Therapeutics To Present ELI-002 7P Tri...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
